We created an algorithm that allows high-throughput mapping of sense-antisense (SA) pairs of transcripts. By this method we mapped approximately 32,000 SA pairs of human mRNAs. Collected SA pairs were divided into three groups: SA pairs based on two or more UniGene clusters (17% of all sense-antisense pairs), SA pairs based on ESTs that belong to the same UniGene cluster (42%), and SA pairs formed by UniGene cluster and non-unique unclustered transcripts (41%). To study expression patterns of natural SA pairs we created a software application "Antisense Cluster Filter". We retrieved tissue expression data for all the transcripts forming identified SA pairs, including clustered and unclustered ones. After that, we selected 108 SA pairs represented by transcripts differentially regulated in human tumors. For each of these SA pairs one of the transcripts was expressed only in tumors, another one was expressed both in non-malignant and malignant tissues. Indicated SA pairs may represent a new class of tumor markers. An example of the tumor-specific natural antisense to C3orf4 mRNA is detailed.
Introduction
The availability of the complete human genome sequence 1,2 and the accumulation of millions of expressed sequences (mRNAs and ESTs) allowed one to perform large-scale studies of naturally occurring antisense transcription. Indeed, in the past two years, several studies have used publicly available sources of information in attempts to produce comprehensive datasets of sense-antisense pairs [3] [4] [5] [6] [7] . Both mRNA expression in a eukaryotic cell and efficiency of its translation into proteins are controlled by multiple regulatory levels subsequent to transcription initiation. As mRNA is a single strand molecule, the expression of a complementary antisense strand may alter the rate of transcription initiation and elongation, mRNA processing and stability, as well as the rate of translation of the template RNA 7 . Functional antisense
RNAs have been identified in bacteria 8 , but later were shown to be involved in gene regulation and differentiation in several eukaryotic organisms, including mammals 7 .
Natural antisense transcripts usually arise via separate transcription initiation on the opposite DNA strand at the same genomic locus as the sense strand. Computational analysis of the data obtained in large-scale sequencing projects has revealed a surprising abundance of antisense transcripts in several eukaryotic genomes. As some antisense transcripts have been shown to regulate gene expression, it is possible that antisense production might be a common mechanism regulating gene expression in eukaryotic cells. Tumors are characterized by general deregulation of transcription initiation revealing itself as "illegitimate transcription" or "mass-production of non-coding RNAs" 9, 10 . We hypothesized that this phenomenon could be partially explained by differential regulation of antisense transcripts in human tumors and found 108 sense-antisense (SA) pairs represented by such transcripts. For each of these SA pairs one of the transcripts was expressed only in normal tissues, another one was expressed only in tumors. Indicated SA pairs may represent a new class of tumor markers.
Materials and methods
Publicly available complete set of human ESTs mapped to human genome was retrieved from GenBank (http://www.ncbi.nlm.nih.gov/entrez/query. fcgi?db =Nucleotide). Information on human EST clusters was retrieved from UniGene (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). Solitary ESTs mapped to human genome as singletons not supported by any UniGene clusters were considered as potential artifacts and were excluded from further studies. Non-solitary ESTs obtained from independent cDNA molecules were considered as true representatives of transcriptome even if they were not supported by existing UniGene clusters. cDNA library descriptions available from CGAP website (CGAP http://cgap.nci.nih.gov/) and other sources 10 were used.
We created an algorithm "Antisense Cluster Filter" implemented in C++. This algorithm allows high-throughput mapping of sense-antisense (SA) pairs of transcripts by 1) retrieving all overlapping pairs that are located on different DNA strands with more than 20 nucleotide overlaps; 2) retrieving all pairs of transcripts that are associated with UniGene clusters; 3) retrieving an intersection of two sets of the above-mentioned sequences. EST clusters containing less than three ESTs were filtered out. Mapping was performed by comparing exact coordinates of the transcript and its orientations on the plus/minus chains of the human genome of the NCBI assembly 35 v. 1 (ftp://ftp.ncbi.nih.gov/genebank/genomes/H_Sapiens). See algorithm schematic in Fig.1 .
Natural tumor-specific SA pairs were selected for further analysis according to the following criteria: 1) sense cluster contains more than 10 ESTs; 2) antisense cluster contains more than 10 ESTs; 3) antisense cluster contains no more than 10% of ESTs originating in non-malignant tissues.
Results

In silico search for natural antisense transcripts in human genome.
Algorithm "Antisense Searcher" allowed us to retrieve approximately 32,000 senseantisense human (SA) pairs and map them on human genome (Fig.1) . Collected SA pairs were divided into three groups: SA pairs based on two or more UniGene clusters (17%), SA pairs based on ESTs that belong to the same UniGene cluster (42%), and SA pairs formed by UniGene cluster and non-solitary unclustered transcripts (41% of all pairs). To study expression patterns of natural SA pairs we created an algorithm "Antisense Cluster Filter" implemented in C++. This software allowed us to retrieve tissue expression data for all the transcripts forming identified SA pairs, including clustered and unclustered ones.
According to tissue expression data, we selected 108 SA pairs represented by transcripts differentially regulated in human tumors. For each of these SA pairs one of the transcripts was expressed only in tumors, another one was expressed both in nonmalignant and malignant tissue sources. One of the most prominent examples of tumorspecific SA pairs is described on Fig. 2 . Indicated SA pairs may represent a new class of tumor markers. 
Discussion
Tumor markers serve as valuable instruments of tumor detection and monitoring, but sensitivity and specificity of tumor marker assays remain regrettably low. Most probably, the future is in tumor detection panels encompassing anywhere from a dozen to hundreds of marker molecules. The level of expression of such markers in each individual tumor most likely is a function of the degree of derangement in the rates of transcription initiation, in alternative splicing events, and in the suppression of the intron retention. An increase in the level of antisense transcription could be one of the facets of tumor-specific expression derangement. Such an increase will reveal itself in novel sense-antisense (SA) pairs arising in tumor tissue. If the sense molecule possesses tumor suppressor function, indicated antisense molecules may serve as potential oncogenes by downregulation of the cellular level of sense transcript. Expression of such oncogenic antisense transcripts will be subject to positive selection, which will lead to an increase in the percentage of tumor cells expressing antisense within a tumor mass. This, in turn, will increase the chances of antisense transcript detection, and will allow one to profile tumor progression as an increase in antisense transcript levels in subsequent samples taken from the tumor mass. If a sense molecule does not possess tumor suppressive function, the relative level of the antisense molecule expressed de novo still could serve as an indicator of tumor progression, as it reflects a combination of per cell and per locus rate of antisense transcription in a given tumor specimen. Based on this logic, we propose that a targeted search for tumor-specific SA pairs might yield a novel set of tumor marker candidates deserving attention both for tumor monitoring and tumor vaccine research. In this study we attempted to select the first set of such candidates.
An example detailed in this paper is a tumor-specific natural antisense to recently characterized human gene C3orf4 located at 3q12.1
11
. This gene is predominantly expressed in cultured oligodendrocytes, the myelinating cells of the central nervous system, but not in astrocytes. In addition to brain, C3orf4 transcripts are found in the heart and, in lesser amounts, in other adult and fetal tissues 11 . Analysis of the corresponding UniGene cluster Hs.107393 supports experimental data. It was previously hypothesized that the C3orf4 gene encodes a membrane protein that could be involved in the differentiation processes at the interface between oligodendrocytes and neurons 11 . In addition to that, we found that expression levels of C3orf4 in tumors may be perturbed by the natural antisense interference. It is tempting to speculate that the loss of C3orf4 function caused by illegitimate antisense RNA production may support the suppression of the cell differentiation and, therefore, may uphold the tumor phenotype. In our opinion, this and other tumor-specific natural antisense molecules may serve as tumor marker candidates suitable for further experimental studies. 
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